Low SLC7A5 mRNA expression was positively associated with favorable prognosis in both DFS and OS in all breast cancer patients analyzed (P = 0.002 and P = 0.0005, respectively; Supplementary Fig. S2a,b). Here, SLC7A5 is linked to breast carcinoma.